Skip to content

Clinical trials

Phase 1 Leukemia, Lymphocytic, Chronic, B-Cell trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Phase: Phase 1 Country / region: France Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20114
20142
20152
20161
20181
20193
20202
20214
20224
20235
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated6
Active, not recruiting4
Recruiting3
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC7
AbbVie2
Genentech, Inc.2
Hoffmann-La Roche2
Hutchmed2
Boehringer Ingelheim1
Boston Medical Center1
Bristol-Myers Squibb1
Celgene1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell31
Lymphoma, Non-Hodgkin18
Lymphoma, Large B-Cell, Diffuse10
Lymphoma, Mantle-Cell10
Lymphoma, Follicular9
Lymphoma, B-Cell, Marginal Zone8
Waldenstrom Macroglobulinemia6
Leukemia, Myeloid, Acute5
Lymphoma5
Multiple Myeloma5

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.